US 12,264,133 B2
Compounds, compositions and methods
Bradley Paul Morgan, South San Francisco, CA (US); Alex Muci, South San Francisco, CA (US); Pu-Ping Lu, South San Francisco, CA (US); Todd Tochimoto, South San Francisco, CA (US); David J. Morgans, Jr., South San Francisco, CA (US); and Erica Anne Kraynack, South San Francisco, CA (US)
Assigned to CYTOKINETICS, INCORPORATED, South San Francisco, CA (US)
Filed by Cytokinetics, Inc., South San Francisco, CA (US)
Filed on Oct. 22, 2021, as Appl. No. 17/452,025.
Application 17/452,025 is a continuation of application No. 17/200,174, filed on Mar. 12, 2021, abandoned.
Application 17/200,174 is a continuation of application No. 16/459,754, filed on Jul. 2, 2019, granted, now 10,975,034, issued on Apr. 13, 2021.
Application 16/459,754 is a continuation of application No. 16/021,418, filed on Jun. 28, 2018, granted, now 10,385,023, issued on Aug. 20, 2019.
Application 16/021,418 is a continuation of application No. 15/480,618, filed on Apr. 6, 2017, granted, now 10,035,770, issued on Jul. 31, 2018.
Application 15/480,618 is a continuation of application No. 14/837,201, filed on Aug. 27, 2015, granted, now 9,643,925, issued on May 9, 2017.
Application 14/837,201 is a continuation of application No. 14/489,705, filed on Sep. 18, 2014, granted, now 9,150,564, issued on Oct. 6, 2015.
Application 14/489,705 is a continuation of application No. 13/946,353, filed on Jul. 19, 2013, granted, now 8,871,769, issued on Oct. 28, 2014.
Application 13/946,353 is a continuation of application No. 13/341,413, filed on Dec. 30, 2011, granted, now 8,513,257, issued on Aug. 20, 2013.
Application 13/341,413 is a continuation of application No. 11/630,062, granted, now 8,110,595, issued on Feb. 7, 2012, previously published as PCT/US2005/021100, filed on Jun. 16, 2005.
Claims priority of provisional application 60/581,197, filed on Jun. 17, 2004.
Prior Publication US 2022/0185779 A1, Jun. 16, 2022
Int. Cl. C07D 241/04 (2006.01); C07D 211/56 (2006.01); C07D 213/75 (2006.01); C07D 239/42 (2006.01); C07D 261/14 (2006.01); C07D 263/48 (2006.01); C07D 271/113 (2006.01); C07D 295/26 (2006.01); C07D 401/10 (2006.01); C07D 401/12 (2006.01); C07D 417/00 (2006.01); C07D 417/10 (2006.01); C07D 417/12 (2006.01); C07D 487/04 (2006.01); C07D 491/04 (2006.01); C07D 513/04 (2006.01)
CPC C07D 213/75 (2013.01) [C07D 211/56 (2013.01); C07D 239/42 (2013.01); C07D 261/14 (2013.01); C07D 263/48 (2013.01); C07D 271/113 (2013.01); C07D 295/26 (2013.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 417/00 (2013.01); C07D 417/10 (2013.01); C07D 417/12 (2013.01); C07D 487/04 (2013.01); C07D 491/04 (2013.01); C07D 513/04 (2013.01)] 15 Claims
 
1. A compound of Formula 1D:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.